Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

295
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
295
Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.0K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.0K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

275
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
275
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

72
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurosurgical and prehospital timing in severe traumatic brain injury: Insights from the prospective Resuscitation Outcomes Consortium hypertonic saline trial.

The journal of trauma and acute care surgery·2026
Same author

Hospital Medicaid payer mix associated with inpatient mortality following traumatic brain injury.

The journal of trauma and acute care surgery·2026
Same author

Physiology-informed machine learning for patient-level surgical decision-making in severe traumatic brain injury: Multicenter model development with external validation.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Combination of Albumin and Cilostazol Improves Outcomes in a Rodent Model of Aneurysmal Subarachnoid Hemorrhage.

Neurocritical care·2026
Same author

Cost-utility framework to evaluate therapeutic interventions targeting reduction in cerebral infarction among aneurysmal subarachnoid hemorrhage patients.

Neurosurgical review·2026
Same author

Incidence and outcomes of unplanned escalation-of-care complications for patients with traumatic brain injury.

Clinical neurology and neurosurgery·2026
Same journal

Treatment of genitourinary syndrome of menopause with fractional COâ‚‚ laser versus fractional microablative radiofrequency: study protocol for a double-blind, randomised, non-inferiority trial.

Trials·2026
Same journal

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.

Trials·2026
Same journal

Scaling up community-based non-communicable disease research into practice in Pokhara Metropolitan City of Nepal (SCALE-NCD) trial: study protocol for a cluster-randomized controlled trial.

Trials·2026
Same journal

EECP intervention and coronary flow reserve in chronic coronary syndrome: a protocol of a multicentre, randomised controlled study in China (ECP-Core Trial).

Trials·2026
Same journal

Impact of early tracheostomy in infratentorial lesions trial: rationale and design.

Trials·2026
Same journal

Efficacy of transcranial direct current stimulation for post-stroke urinary incontinence: study protocol for a randomized controlled trial.

Trials·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.

Caitlyn Meinzer1, Renee Martin2, Jose I Suarez3

  • 1Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, SC, USA. ellerbcn@musc.edu.

Trials
|September 10, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Bayesian adaptive design for phase II trials to efficiently identify optimal drug doses. The restricted response adaptive randomization balances dose selection with maintaining statistical power for efficacy testing.

Keywords:
Adaptive designBayesian designClinical trialDose selectionPhase IIResponse adaptive randomization

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

710
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

710
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.5K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmacometrics

Background:

  • Phase II trials often struggle to identify the most effective drug dose due to limited resources and the need to simultaneously assess efficacy.
  • Adaptive trial designs offer efficiency but can risk incorrect assumptions and reduced data across the dose range due to imbalanced sample sizes.

Purpose of the Study:

  • To present a novel placebo-controlled design using restricted Bayesian response adaptive randomization (RAR) for phase II trials.
  • To balance the challenges of dose identification and efficacy testing within resource constraints.

Main Methods:

  • Employs a restricted Bayesian response adaptive randomization (RAR) to allocate more subjects to the optimal dose.
  • Maintains a constant allocation ratio between active drug and placebo to maximize power for efficacy hypothesis testing.
  • Illustrates design properties and optimization using a phase II trial for subarachnoid hemorrhage.

Main Results:

  • A trade-off exists between optimal dose selection and the probability of rejecting the null hypothesis for a fixed sample size.
  • Allocation ratios, RAR algorithm choice, and initial fixed allocation periods influence this trade-off.
  • Responsive RAR improves dose selection but may increase the risk of assigning subjects to suboptimal arms based on temporary data trends.

Conclusions:

  • Bayesian adaptive designs offer flexibility for optimizing treatment efficacy in resource-limited settings.
  • Further research is needed for interim analyses and incorporating dose-response models into these adaptive designs.